Market Overview:
The EPA and DHA Market, comprising Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA), has experienced notable expansion in recent years. These extended-chain omega-3 fatty acids serve as fundamental components in fish oil and algae-derived supplements, catering to a diverse array of sectors, including pharmaceuticals, nutraceuticals, and functional foods.
The market's upward trajectory is primarily driven by the heightened awareness among consumers regarding the health advantages linked to EPA and DHA, encompassing cardiovascular health, cognitive functionality, and anti-inflammatory properties. The escalating trend towards preventive healthcare practices and the integration of omega-3 supplements into dietary regimens play pivotal roles in contributing to the market's robust growth.
EPA and DHA Market was USD 1,670.04 million in 2022 It is projected to reach USD 2,680.43 million by 2030, indicating a CAGR of 6.2% during the forecast period.
Market Key Players:
KD Pharma Group, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Omega Protein Corporation, Croda International PLC, Novotech Nutraceuticals, Polaris SA, and AlgalR NutraPharms Pvt. Ltd
Market key drivers:
The momentum propelling the expansion of the EPA and DHA market is underpinned by several critical factors. A burgeoning focus on health and wellness, a surge in chronic disease prevalence, and the pursuit of nutritional solutions by an aging population stand out as primary drivers. Furthermore, the market is significantly influenced by the increasing favorability of omega-3-fortified products, complemented by advancements in extraction technologies that play a pivotal role in facilitating market growth. Noteworthy is the escalating demand for sustainable and plant-based sources of EPA and DHA, driven by environmental apprehensions and ethical considerations, which is actively shaping both product innovation and the overarching dynamics of the market.
Market Segmentation:
By Type
By Source
By Application
Regional Analysis:
The Asia-Pacific region has emerged as the primary contributor to market growth, attributing its prominence to the burgeoning pharmaceutical sector. Notably, the pharmaceuticals industry in India, as highlighted by the India Brand Equity Foundation (IBEF), witnessed substantial growth in 2020, reaching a valuation of USD 42.0 billion.
Projections indicate a remarkable surge to USD 65.0 billion by 2024, reflecting a robust increase of 54.8%. This remarkable progress in the pharmaceutical domain is a pivotal factor propelling the revenue expansion of the EPA and DHA market in the region.
Click Here To Get: EPA and DHA Market Benefits
About Us:
Consegic Business Intelligence Pvt Ltd. is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domains. The industry provides consulting services, syndicated research reports, and customized research reports.
Topnotch research organizations and institutions to comprehend the regional and global commercial status use the data produced by Consegic Business Intelligence Pvt Ltd. Our reports comprise in-depth analytical and statistical analysis on various industries in foremost countries around the globe.
Contact us:
Consegic Business intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: [email protected]
Post articles and opinions on Professionals UK
to attract new clients and referrals. Feature in newsletters.
Join for free today and upload your articles for new contacts to read and enquire further.
